Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

Article  PubMed  Google Scholar 

Chen, Y. C. et al. Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022. Gastroenterology 166, 605–619 (2024).

Article  PubMed  Google Scholar 

You, W. C. et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J. Natl Cancer Inst. 92, 1607–1612 (2000).

Article  CAS  PubMed  Google Scholar 

Correa, P. Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 52, 6735–6740 (1992).

Correa, P. et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J. Natl Cancer Inst. 92, 1881–1888 (2000).

Article  CAS  PubMed  Google Scholar 

Piazuelo, M. B. et al. The Colombian Chemoprevention Trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions. Gastroenterology 160, 1106–1117 (2021).

Article  PubMed  Google Scholar 

Saito, D. et al. Impact of H. pylori eradication on gastric cancer prevention: endoscopic results of the Japanese intervention trial (JITHP-study). A randomized multi-center trial. Gastroenterology 128, A4 (2005).

Google Scholar 

Choi, I. J. et al. Family history of gastric cancer and Helicobacter pylori treatment. N. Engl. J. Med. 382, 427–436 (2020).

Article  PubMed  Google Scholar 

Wong, B. C. et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291, 187–194 (2004).

Article  CAS  PubMed  Google Scholar 

Yan, L. et al. Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up. Gastroenterology 163, 154–162 (2022).

Article  CAS  PubMed  Google Scholar 

Leung, W. K. et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 53, 1244–1249 (2004).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou, L. et al. Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study. Chin. Med. J. (Engl.) 127, 1454–1458 (2014).

PubMed  Google Scholar 

You, W. C. et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J. Natl Cancer Inst. 98, 974–983 (2006).

Article  PubMed  Google Scholar 

Ma, J. L. et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J. Natl Cancer Inst. 104, 488–492 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, W. Q. et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial. Br. Med. J. 366, l5016 (2019).

Article  Google Scholar 

Li, W. Q. et al. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J. Natl Cancer Inst. 106, dju116 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Wong, B. C. et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut 61, 812–818 (2012).

Article  CAS  PubMed  Google Scholar 

You, W. C. et al. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res. 53, 1317–1321 (1993).

CAS  PubMed  Google Scholar 

Ford, A. C., Yuan, Y. & Moayyedi, P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut 69, 2113–2121 (2020).

Article  PubMed  Google Scholar 

Ford, A. C., Yuan, Y. & Moayyedi, P. Long-term impact of Helicobacter pylori eradication therapy on gastric cancer incidence and mortality in healthy infected individuals: a meta-analysis beyond 10 years of follow-up. Gastroenterology 163, 754–756 (2022).

Article  PubMed  Google Scholar 

Helicobacter pylori Working Group. Helicobacter pylori eradication as a strategy for preventing gastric cancer. IARC Working Group Report Vol. 8 (IARC, 2014); https://publications.iarc.fr/Book-And-Report-Series/Iarc-Working-Group-Reports/-Em-Helicobacter-Pylori-Em-Eradication-As-A-Strategy-For-Preventing-Gastric-Cancer-2014

Gao, H. et al. Systematic review with meta-analysis: association of helicobacter pylori infection with esophageal cancer. Gastroenterol. Res. Pract. 2019, 1953497 (2019).

Article  PubMed  PubMed Central  Google Scholar 

El-Serag, H. B. et al. Houston Consensus Conference on Testing for Helicobacter pylori infection in the United States. Clin. Gastroenterol. Hepatol. 16, 992–1002 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Malfertheiner, P. et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut 71, 1724–1762 (2022).

Article  CAS  Google Scholar 

Sugano, K. et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 64, 1353–1367 (2015).

Article  PubMed  Google Scholar 

Gupta, S. et al. AGA clinical practice guidelines on management of gastric intestinal metaplasia. Gastroenterology 158, 693–702 (2020).

Article  PubMed  Google Scholar 

Pan, K. F. et al. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication. Gut 65, 9–18 (2016).

Article  CAS  PubMed  Google Scholar 

Zhou, L. et al. 2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment. Chin. Med. J. (Engl.) 135, 2899–2910 (2022).

Article  PubMed  Google Scholar 

Song, Z. et al. Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients. Dig. Liver Dis. 46, 1077–1081 (2014).

Article  CAS  PubMed  Google Scholar 

Chen, J. et al. Primary antibiotic resistance of Helicobacter pylori in different regions of China: a systematic review and meta-analysis. Pathogens 11, 786 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Francesco, V. et al. Worldwide H. pylori antibiotic resistance: a systematic review. J. Gastrointestin. Liver Dis. 19, 409–414 (2010).

PubMed  Google Scholar 

Camargo, M. C. et al. The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America. Am. J. Gastroenterol. 109, 485–495 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuo, Y. T. et al. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2, 707–715 (2017).

Article  PubMed  Google Scholar 

Savoldi, A., Carrara, E., Graham, D. Y., Conti, M. & Tacconelli, E. Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions. Gastroenterology 155, 1372–1382 (2018).

Article  PubMed  Google Scholar 

Chey, W. D., Leontiadis, G. I., Howden, C. W. & Moss, S. F. ACG clinical guideline: treatment of Helicobacter pylori infection. Am. J. Gastroenterol. 112, 212–239 (2017).

Article  PubMed  Google Scholar 

Fallone, C. A., Moss, S. F. & Malfertheiner, P. Reconciliation of recent Helicobacter pylori treatment guidelines in a time of increasing resistance to antibiotics. Gastroenterology 157, 44–53 (2019).